Skip Navigation

Phase III Randomized Adjuvant Study of MK-3475 Pembrolizumab in Muscle Invasive and Locally Advanced Urothelial Carcinoma AMBASSADOR versus Observation

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03244384

Study #:
STUDY00142042

Start Date:
Mar 29, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03244384

View Complete Trial Details & Eligibility at ClinicalTrials.gov